491 related articles for article (PubMed ID: 9632369)
1. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of N-(1-benzylpiperidin-4-yl)arylacetamide analogues as potent sigma1 receptor ligands.
Huang Y; Hammond PS; Wu L; Mach RH
J Med Chem; 2001 Dec; 44(25):4404-15. PubMed ID: 11728186
[TBL] [Abstract][Full Text] [Related]
3. N-[omega-(Tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine are highly potent and selective sigma1 or sigma2 ligands.
Berardi F; Santoro S; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1998 Oct; 41(21):3940-7. PubMed ID: 9767631
[TBL] [Abstract][Full Text] [Related]
4. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
[TBL] [Abstract][Full Text] [Related]
5. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands.
Moussa IA; Banister SD; Beinat C; Giboureau N; Reynolds AJ; Kassiou M
J Med Chem; 2010 Aug; 53(16):6228-39. PubMed ID: 20662542
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of chiral 1-[omega-(4-chlorophenoxy)alkyl]-4-methylpiperidines and their biological evaluation at sigma1, sigma2, and sterol delta8-delta7 isomerase sites.
Berardi F; Loiodice F; Fracchiolla G; Colabufo NA; Perrone R; Tortorella V
J Med Chem; 2003 May; 46(11):2117-24. PubMed ID: 12747784
[TBL] [Abstract][Full Text] [Related]
8. Novel sigma receptor ligands: synthesis and biological profile.
Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
[TBL] [Abstract][Full Text] [Related]
9. (+)-cis-N-ethyleneamino-N-normetazocine derivatives. Novel and selective sigma ligands with antagonist properties.
Ronsisvalle G; Marrazzo A; Prezzavento O; Pasquinucci L; Vittorio F; Pittalà V; Pappalardo MS; Cacciaguerra S; Spampinato S
J Med Chem; 1998 May; 41(10):1574-80. PubMed ID: 9572883
[TBL] [Abstract][Full Text] [Related]
10. Substituted benzylaminoalkylindoles with preference for the sigma2 binding site.
Mamolo MG; Zampieri D; Zanette C; Florio C; Collina S; Urbano M; Azzolina O; Vio L
Eur J Med Chem; 2008 Oct; 43(10):2073-81. PubMed ID: 18069094
[TBL] [Abstract][Full Text] [Related]
11. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.
Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L
Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of spirocyclic sigma1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability.
Grosse Maestrup E; Wiese C; Schepmann D; Hiller A; Fischer S; Scheunemann M; Brust P; Wünsch B
Bioorg Med Chem; 2009 May; 17(10):3630-41. PubMed ID: 19394833
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of σ1 ligands.
Sadeghzadeh M; Sheibani S; Ghandi M; Daha FJ; Amanlou M; Arjmand M; Hasani Bozcheloie A
Eur J Med Chem; 2013 Jun; 64():488-97. PubMed ID: 23680866
[TBL] [Abstract][Full Text] [Related]
14. Chiral, nonracemic (piperazin-2-yl)methanol derivatives with sigma-receptor affinity.
Bedürftig S; Wünsch B
Bioorg Med Chem; 2004 Jun; 12(12):3299-311. PubMed ID: 15158798
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
Zampieri D; Laurini E; Vio L; Golob S; Fermeglia M; Pricl S; Mamolo MG
Bioorg Med Chem Lett; 2014 Feb; 24(4):1021-5. PubMed ID: 24486131
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of aryl-substituted N-(arylethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamines and corresponding arylacetamides for sigma receptor affinity.
Zhang Y; Williams W; Bowen WD; Rice KC
J Med Chem; 1996 Aug; 39(18):3564-8. PubMed ID: 8784455
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands.
Huang Y; Luedtke RR; Freeman RA; Wu L; Mach RH
J Med Chem; 2001 May; 44(11):1815-26. PubMed ID: 11356115
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma2 ligands.
Couture S; Debonnel G
Synapse; 1998 May; 29(1):62-71. PubMed ID: 9552175
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
Chen YY; Wang X; Zhang JM; Deuther-Conrad W; Zhang XJ; Huang Y; Li Y; Ye JJ; Cui MC; Steinbach J; Brust P; Liu BL; Jia HM
Bioorg Med Chem; 2014 Oct; 22(19):5270-8. PubMed ID: 25189691
[TBL] [Abstract][Full Text] [Related]
20. Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands.
Mach RH; Huang Y; Freeman RA; Wu L; Vangveravong S; Luedtke RR
Bioorg Med Chem Lett; 2004 Jan; 14(1):195-202. PubMed ID: 14684327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
